A clinical trial to compare efficacy of nebulisation with hypertonic saline and epinephrine in children with Acute Bronchiolitis
Phase 1
- Conditions
- Health Condition 1: null- presenting with first episode of wheeze with fever or cough. age group from 1 month to 5 years
- Registration Number
- CTRI/2015/12/006458
- Lead Sponsor
- BPKIHS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All children between 1 month and 5 years of age with the diagnosis of acute bronchiolitis. Bronchiolitis taken as the first episode of wheezing associated with clinical evidence of viral infection (cough, coryza or fever).
Exclusion Criteria
children over 5 yrs of age
•not giving consent
•Multiple episodes of wheezing
•Children already on bronchodilators or any other medication
•Children with history of allergic rhinitis, atopic dermatitis.
•Children with cardiac disease
•Children with chronic pulmonary disease
•Children with obtunded consciousness
•Children with progressive respiratory failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to compare the efficacy of the nebulisation with ephrinephrine to hypertonic salineTimepoint: to compare the efficacy of the nebulisation with ephrinephrine to hypertonic saline
- Secondary Outcome Measures
Name Time Method to compare the safety of nebulisation with epinephrine and hypertonic salineTimepoint: 1 year